Cargando…

Impact of Gastrointestinal Symptoms on Health-Related Quality of Life in an Australian Parkinson's Disease Cohort

BACKGROUND: Gastrointestinal symptoms (GIS) in people with Parkinson's disease (PwP) are often underreported and may remain untreated. Constipation is a common nonmotor symptom that can adversely affect health-related quality of life (QoL); however, the impact of other GIS has not been adequate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kenna, Jade E., Bakeberg, Megan C., Abonnel, Maddison Y., Mastaglia, Frank L., Anderton, Ryan S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718626/ https://www.ncbi.nlm.nih.gov/pubmed/36466568 http://dx.doi.org/10.1155/2022/4053665

Ejemplares similares

Changes in the Gut Microbiome and Predicted Functional Metabolic Effects in an Australian Parkinson’s Disease Cohort
por: Kenna, Jade E., et al.
Publicado: (2021)

Quality of life implications for elevated trait impulsivity in people with Parkinson’s disease
por: Jeyadevan, Ashani, et al.
Publicado: (2023)

The TOMM40 ‘523’ polymorphism in disease risk and age of symptom onset in two independent cohorts of Parkinson’s disease
por: Bakeberg, Megan C., et al.
Publicado: (2021)

Trait Impulsivity Is Independent of Mild Cognitive Impairment in a Parkinson's Disease Cohort
por: Jeyadevan, Ashani, et al.
Publicado: (2019)

Altered Gut Microbiome in Parkinson’s Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model
por: Gorecki, Anastazja M., et al.
Publicado: (2019)

Demographic and Clinical Predictors of Trait Impulsivity in Parkinson's Disease Patients
por: Riley, Maddeson, et al.
Publicado: (2018)

Elevated HDL Levels Linked to Poorer Cognitive Ability in Females With Parkinson’s Disease
por: Bakeberg, Megan C., et al.
Publicado: (2021)

Single Nucleotide Polymorphisms Associated With Gut Homeostasis Influence Risk and Age-at-Onset of Parkinson's Disease
por: Gorecki, Anastazja M., et al.
Publicado: (2020)

Elevated Serum Homocysteine Levels Have Differential Gender-Specific Associations with Motor and Cognitive States in Parkinson's Disease
por: Bakeberg, Megan C., et al.
Publicado: (2019)

Differential effects of sex on longitudinal patterns of cognitive decline in Parkinson’s disease
por: Bakeberg, Megan C., et al.
Publicado: (2021)

TOMM40‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s disease
por: Bakeberg, Megan C., et al.
Publicado: (2021)

Elevated Serum Ceruloplasmin Levels Are Associated with Higher Impulsivity in People with Parkinson's Disease
por: Bakeberg, Megan C., et al.
Publicado: (2020)

SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians
por: Huang, Yue, et al.
Publicado: (2015)

Proteomic analysis of cortical neuronal cultures treated with poly-arginine peptide-18 (R18) and exposed to glutamic acid excitotoxicity
por: MacDougall, Gabriella, et al.
Publicado: (2019)

Intronic NEFH variant is associated with reduced risk for sporadic ALS and later age of disease onset
por: Theunissen, Frances, et al.
Publicado: (2022)

Quality of life and psychological and gastrointestinal symptoms after cholecystectomy: a population-based cohort study
por: Talseth, Arne, et al.
Publicado: (2017)

Health-related quality of life and strain in caregivers of Australians with Parkinson’s disease: An observational study
por: Kelly, David H, et al.
Publicado: (2012)

Plant-based dietary quality and depressive symptoms in Australian vegans and vegetarians: a cross-sectional study
por: Lee, Megan Frances, et al.
Publicado: (2021)

Non-Motor Symptoms of Parkinson’s Disease and Their Impact on Quality of Life in a Cohort of Moroccan Patients
por: Tibar, Houyam, et al.
Publicado: (2018)

Poly-arginine-18 (R18) Confers Neuroprotection through Glutamate Receptor Modulation, Intracellular Calcium Reduction, and Preservation of Mitochondrial Function
por: MacDougall, Gabriella, et al.
Publicado: (2020)

Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments
por: Poirier, Andrée-Anne, et al.
Publicado: (2016)

Comparison of neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the Wistar rat and in vitro toxicity studies
por: Milani, Diego, et al.
Publicado: (2018)

Cognitive Influences in Parkinson's Disease Patients and Their Caregivers: Perspectives From an Australian Cohort
por: Lubomski, Michal, et al.
Publicado: (2021)

Clinical Symptoms Influencing Parkinson’s Patients’ Quality of Life in Latvia: A Single-Center Cohort Study
por: Minibajeva, Olga, et al.
Publicado: (2023)

Cohort profile: Dementia in the Registry of Senior Australians
por: Cations, Monica, et al.
Publicado: (2021)

Genetic predictors of match performance in sub-elite Australian football players: A pilot study
por: Jacob, Ysabel, et al.
Publicado: (2019)

Prevalence of Malnutrition in Parkinson's Disease and Correlation with Gastrointestinal Symptoms
por: Paul, Birinder Singh, et al.
Publicado: (2019)

Gastrointestinal Dysfunction Impact on Life Quality in a Cohort of Russian Patients with Parkinson's Disease I-III H&Y Stage
por: Pilipovich, A. A., et al.
Publicado: (2022)

Relation of Subjective Quality of Life to Motor Symptom Profile in Parkinson's Disease
por: Appleman, Erica R., et al.
Publicado: (2011)

The impact of nonmotor symptoms on quality of life in patients with Parkinson’s disease in Taiwan
por: Liu, Weng-Ming, et al.
Publicado: (2015)

Sicca Symptoms in Parkinson's Disease: Association with Other Nonmotor Symptoms and Health-Related Quality of Life
por: Prell, Tino, et al.
Publicado: (2020)

Patient-Reported Gastrointestinal Symptoms and the Association With Quality of Life Following Kidney Transplantation
por: Chan, Samuel, et al.
Publicado: (2020)

Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era
por: Li, Dunhui, et al.
Publicado: (2020)

The Frequency and Severity of Gastrointestinal Symptoms in Patients with Early Parkinson’s Disease
por: Sung, Hye-Young, et al.
Publicado: (2014)

Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's Disease
por: Murtomäki, Kirsi, et al.
Publicado: (2022)

The SYMPTOM‐upper gastrointestinal study: A mixed methods study exploring symptom appraisal and help‐seeking in Australian upper gastrointestinal cancer patients
por: Karnchanachari, Napin, et al.
Publicado: (2022)

Association of Motor and Nonmotor Symptoms With Health-Related Quality of Life in a Large Online Cohort of People With Parkinson Disease
por: Bock, Meredith A., et al.
Publicado: (2022)

Impact of Sex on the Nonmotor Symptoms and the Health-Related Quality of Life in Parkinson's Disease
por: Kovács, Márton, et al.
Publicado: (2016)

Profile of Nonmotor Symptoms and the Association with the Quality of Life of Parkinson's Disease Patients in Nigeria
por: Arabambi, Babawale, et al.
Publicado: (2019)

Relationship between Motor and Nonmotor Symptoms and Quality of Life in Patients with Parkinson’s Disease
por: Candel-Parra, Eduardo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1glq0771d9ndllqndp3vu1mq04